RUNNING POINT CAPITAL ADVISORS, LLC Atara Biotherapeutics, Inc. Transaction History

RUNNING POINT CAPITAL ADVISORS, LLC portfolio value:

$38,000
portfolio value

RUNNING POINT CAPITAL ADVISORS, LLC quarter portfolio value change:

-51.48%
quarter

Atara Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -40K $3.78 10K
Q2 2022 share 0.00% 0 shares -15K $7.79 10K
Q1 2022 share Increase 0.00% 10K shares 93K $9.29 10K